• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 97 of 100
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FinancePfizer to acquire Hospira in a deal worth about $15 billion
By Fortune EditorsFebruary 5, 2015
Close-up of various intravenous solutions used during operations
FeaturesThere’s a national shortage of saline solution. Yeah, we’re talking salt water. Huh?
By Erika FryFebruary 5, 2015
Earns Pfizer
FeaturesIn speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
FinanceFDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By Laura LorenzettiFebruary 4, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FeaturesIs it time for the FDA to consider cost when it comes to new drugs?
By Laura LorenzettiFebruary 4, 2015
Inside of a Gilead Sciences Lab
TechBigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Fortune EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
FinanceHow to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
LeadershipFire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FeaturesPfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Negatively-stained Hong Kong Flu Virus
FeaturesOne shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
FeaturesDetroit auto show and Obama on cybersecurity — 5 things to know today
By Laura LorenzettiJanuary 12, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
EyebrowShire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
TechA powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
1...
  • 95
  • 96
  • 97
  • 98
  • 99
100
Most Popular
Middle East
Iran's attacks have collapsed, and the trend is 'overwhelmingly positive,' analysts say. But the military side is separate from politics and marketsAn image of a popular article
By Jason MaMarch 16, 2026
Investing
Peter Thiel is actively convincing billionaires to abandon The Giving Pledge — and it may be workingAn image of a popular article
By Jake AngeloMarch 16, 2026
Politics
'No, we didn’t': DOGE staffer admits Elon Musk’s cost-cutting agency failed to reduce the federal deficitAn image of a popular article
By Sasha RogelbergMarch 16, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.